Mirae Asset Global Investments Co., Ltd. Abbott Laboratories Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Abbott Laboratories stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 184,961 shares of ABT stock, worth $20.9 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
184,961
Previous 149,834
23.44%
Holding current value
$20.9 Million
Previous $15.6 Million
35.44%
% of portfolio
0.09%
Previous 0.08%
Shares
30 transactions
Others Institutions Holding ABT
# of Institutions
3,186Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$18.9 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$14.8 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$8.65 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.42 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.01 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $198B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...